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• Novel composite hydrogels were
formed using whey protein isolate
(waste product from daily industry)
and synthetic aragonite via inexpensive
method.
• The mechanical strength was higher for
composites with higher aragonite con-
tent.
• The proliferation and alkaline phospha-
tase activity of seeded osteoblast-like
cells was higher on composites with
higher aragonite content.
• The composites degraded under physio-
logical conditions with release of non-
cytotoxic degradation products, causing
mineralised extracellular matrix, suit-
able for bone regeneration.
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Inexpensive
This work explores novel biocomposite hydrogels fabricated using 40% (wt/vol) solution of whey protein isolate
(WPI, from the food industry) mixed with increasing concentrations of synthetic aragonite rod-like powder of 0,
100, 200 and 300 mg/ml (namedWPI0, WPI100, WPI200 and WPI300). FTIR results showed that aragonite was
successfully incorporated into theWPI hydrogel network. SEM and micro-CT investigations revealed that arago-
nite was mainly concentrated near the edges of the composite samples, except in WPI300, which had homoge-
neous aragonite distribution. The pore diameters ranged from 18 to 778 μm while averaged pore size was the
lowest for WPI0 at 30 μm and highest for WPI200 at 103 μm. The mean compression modulus was highest for
WPI300 at 3.16 MPa. After 28 days in physiological conditions WPI300 had maximum mean swelling of 4.3%
and there was the highest degradation rate for WPI200 and WPI300 and lowest for WPI100 and WPI0. The
osteoblast-like MG63 cell metabolic and alkaline phosphatase activities in direct contact experiments with
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Degradation
Cytocompatible
composites increased with increasing aragonite content over 3 weeks. Moreover, the degradation products of
these composites were non-cytotoxic and led to mineral-like deposits in extracellular matrix. These WPI-
aragonite biocomposite hydrogels are potent candidates for bone repair applications.
© 2018 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Many orthopedic and dental complications involve the need for
bone graft such as repair of traumatic and congenital defects, spinal sur-
gery and build-up of bone stock around biomedical implants. However,
the autograft or allograft bone most commonly used clinically are in
limited supply [1]. Thus, synthetic biomaterials are widely explored as
bone graft substitutes, these are however, not without limitations,
such as release of toxic waste products, poor cellular responses by
host cells and they may trigger immune responses. Bone graft substi-
tutes can also be extremely expensivewhich limits their use in develop-
ing countries and even in richer developed countries [2]. Hence, there is
now an increasing demand for development of inexpensive biomate-
rials fromnatural resources that can be used for bone tissue engineering
and regenerative applications.
Whey protein (WP) is considered a waste product of cheese
manufacturing in the dairy industry and consists of 85–90% water and
10–15% lactose, proteins, lipids and minerals. The proteins usually in-
clude β-lactoglobulin, α-lactalbumin, glycomacropeptide, immuno-
globulins and bovine serum albumin, which vary in content based on
themethodology used for cheesemanufacturing [3,4].WP in its various
forms as reduced-lactosewhey, demineralizedwhey,wheyprotein con-
centrates, and whey protein isolates (WPI), is used for cosmetic and
pharmaceutical applications and also as emulsifying, thickening, gelling,
foaming, andwater- binding agents [5,6].WP has gainedwidespread at-
tention as a food additive. AsWP is rich in essential amino acids such as
leucine, valine, isoleucine and cysteine, the raw whey can be used for
biotransformation feed, bioproteins, prebiotics and bioactive peptides
after fermentation and enzymatic hydrolysis [4,6].
WPI (a type ofWP) contains at least 90% protein. This is because the
fat and lactose is removed via ion exchange followed by concentration
and spray drying; or microﬁltration followed by ultraﬁltration and
spray drying [7]. WPI solution can undergo gelation by heating to high
temperatures, causing the unfolded proteins to form new inter-and
intra-protein bonds that create a gel network. Gelation can also be
achieved by high pressures, acidiﬁcation or enzymatic hydrolysis [8].
Hydrogelsmade fromWPI arewidely explored as drug delivery vehicles
for controlled drug release [9].
Hydrogels are three dimensional polymeric scaffolds which are hy-
drophilic in nature. They are explored for tissue engineering applica-
tions due to their ability to retain water, easy transport/entrapment of
nutrients or cells, controlled biodegradability (useful for controlled re-
lease of bioactive components), superior mechanical strength, mould-
ability to desired geometry for implantation or injection (for minimally
invasive procedures), excellent biocompatibility and reduced inﬂam-
matory responses [10]. For hard tissue engineering applications,
hydrogels are often combined with inorganic components such as hy-
droxyapatite, tricalcium phosphate, bioglass particles or carbon nano-
tubes to increase their mechanical strength and osteoconductivity
[11]. Naturally-derived hydrogels based on collagen, gelatin, alginate
and chitosan have been widely reported [10], however, WPI-based
composite hydrogels have only recently been reported. Dziadek et al.,
[12] developed novel compositeswhereWPI was used as amain hydro-
gel matrix component (40% wt/vol), gelatin as a matrix modiﬁer (20%
wt/vol) and α-tricalcium phosphate (α-TCP) as inorganic component
(20–70% wt/vol). They reported that increasing the α-TCP
concentration linearly improved the mechanical properties of corre-
sponding composites when compared to control hydrogels.
Aragonite is another type of inorganic phase of calcium carbonate of
interest [13,14]. This is a polymorphic form of calcium carbonate natu-
rally derived from marine coral and porous skeleton of marine corals
[15]. Previously, rod-like aragonite crystals have been used to manufac-
ture porous polymeric scaffolds based on neat poly(ε-caprolactone) for
bone tissue engineering applications [16]. Moreover, a recent study
showed that new bone formation was higher in the Porites coral and
Acropora coral constructs than in either the β-tricalcium phosphate or
banked bone constructs in ectopic, subcutaneous-pouch sheep model
[17]. This suggests suitability of aragonite for bone tissue engineering
and regeneration. Therefore, we report here for the ﬁrst time the devel-
opment of novel biocomposite hydrogels based on WPI and aragonite
powder for bone tissue engineering applications.
2. Methods
2.1. Manufacturing of WPI-based biocomposites
A 40%WPI solution was obtained by adding 4 g WPI (Whey Protein
Isolate, Davisco, USA) to 10ml distilled water. After incubation in an ul-
trasonic bath for 20 min, 1 ml WPI solution was put into Eppendorf
tubes. Synthetic aragonite rod-like powder (LUKASIEWICZ - Institute
of Ceramics and Building Materials, ICiBM, Poland) as a source of
CaCO3 [16], was added toWPI solution in three different concentrations
of 100 mg/ml (WPI100), 200 mg/ml (WPI200) and 300 mg/ml
(WPI300). All samples were quickly mixed on vortex to homogenise
andheated at 90 °C for 2min to prevent sedimentation. Finally, the sam-
ples were sterilized by autoclaving in 120 °C for 2 h. WPI hydrogels
without aragonite was also synthesized as a control sample (WPI0).
2.2. Scanning electron microscopy
Morpho-structural characterization of the biocomposites was per-
formed using scanning electron microscopy (SEM). Samples were
coatedwith a 9 nm layer of gold for 3min at 20mA, 0.1mBar usingQuo-
rum Q150RES sputter coater (Quorum Technologies Ltd). SEM images
were acquired using secondary electron detector JSM-7800F (JEOL UK
Ltd., Welvyn Garden City) at accelerating voltage of 5 kV and a working
distance of 10mm. Biological samples were ﬁxed in 3.7% paraformalde-
hyde in PBS, cleaned with sterile distilled water, dehydrated using se-
quential washed with 20%, 40%, 60%, 70%, 80%, 90% and 100% ethanol
followed by drying by evaporation of hexamethyldisilazane, sputter
coated with gold and then visualized under SEM.
2.3. Micro-CT imaging
Micro-CT scanswere recorded using a SkyScan 1272 high-resolution
X-Ray microtomograph (Bruker MicroCT, Belgium). The equipment
uses an X-ray source with peak energies ranging from 20 to 100 kV
and a 6-position automatic ﬁlter changer. The samples were scanned
in sealed 2 ml polypropylene test tubes, as synthesized, to avoid dehy-
dration. The tubes were ﬁxed on the sample holder using modelling
clay. The control sample was scanned without ﬁlter, at 45 kV and
200 μA emission current. In order to get a better contrast between the
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organic and inorganic phase of the composite hydrogels, a ﬁlter of Al
0.5 mm was used. The composites were scanned at a voltage of 70 kV
and an emission current of 140 μA. At least 1100 slices were registered
for each sample with a rotation step of 0.2 and an averaging of 3 frames.
The images were registered at a resolution of 2452 × 2452 and a pixel
size of 9.5 μm for the control samples and 9 μm for the composite sam-
ples. All images were processed using Image J version: 2.0.0-rc-69/
1.52p. 3D tomographies were generated using 3D viewer. The raw im-
ages were thresholded between 0 and 129 for WPI signal and
129–255 for aragonite to identify the distribution of aragonite within
the samples. To investigate any fabrication architecture heterogeneity,
porosity, pore size and strut size (material thickness between pores)
measurements were performed for raw images (without separating
WPI and aragonite) using BoneJ2 plugin in Image J [18].
2.4. Fourier transform infrared spectroscopy
The structure of the samples was examined using Fourier Transform
Infrared (FTIR) Spectroscopy (Agilent Technology, UK). The spectra
were collected between 4500 and 500 cm−1 spectral range with a reso-
lution of 4 cm−1 and an average of 8 scans.
2.5. Compressive strength
The compression modulus of the wet biocomposites was deter-
mined by using a universal testing machine (Inspekt mini; Hegewald
& Peschke Meß- und Prüftechnik GmbH, Nossen, Germany). Displace-
ment rate was set to 2 mm·min−1 until failure of the samples was
reached. The applied force was measured with a 100 N load cell. The
compressive stress σwas then determined from the formula:
σ ¼
F
A
where, F = applied force and A = cross-sectional area (diameter was
assumed to be the same as the internal diameter of the Eppendorf
tube). The compression modulus was determined by the gradient of
the linear-elastic range of the stress-strain curve for small strains.
2.6. Swelling analysis
Autoclaved samples were incubated in simulated body ﬂuid (SBF).
After 1, 4, 7, 14, 21 and 28 days of incubation, sampleswere dried on ab-
sorbent paper to remove unbound water from the surface and then
weighted. The swelling ratio of each sample was calculated as:
weight after swelling−weight before swelling
weight before swelling
 100
2.7. Bicinchoninic acid assay
The samples were incubated in phosphate-buffered saline (PBS,
Gibco) at 37 °C and the amount of protein released into solution was
measured after 1, 4, 7, 21 and 28 days of incubation. The released pro-
tein was calorimetrically detected and quantiﬁed using bicinchoninic
acid (BCA) assay (Pierce BCA Protein Assay Kit, Thermo Fisher Scien-
tiﬁc). Brieﬂy, 25 μl of each solution was put into two wells of 96 well
plates and topped up with 200 μl of BCA working reagent, which was
prepared by mixing 19 ml reagent A and 0.38 ml reagent B until it was
a uniform light green colour. Protein assay containers were sealed and
incubated at 60 °C for 15 min. Absorbance was measured at 562 nm
using a Tecan Inﬁnite 200 Pro (Tecan, UK). Protein content was extrap-
olated using a standard curve from eight serial dilutions of 5 mg/ml so-
lution of WPI in water.
2.8. Preparation of WPI-based composites for cell culture
Autoclaved samples were washedwith PBS three times, followed by
two culture medium washes (see Section 2.9 for culture medium com-
position) and then left in culture medium for 30 min before seeding
cells for direct-contact cytocompatibility experiments or adding culture
medium only for indirect-contact cytocompatibility experiments.
2.9. Culturing of MG63 cells
The MG63 osteoblast-like cells (passage 15 to 28) were maintained
in standard culturemedium composed ofα-MEMEaglewith sodiumbi-
carbonate (Sigma-Aldrich, UK), 10% Foetal Bovine Serum (LabTech, UK),
2mM L-Glutamine and 100mg/ml Penicillin–Streptomycin at 37 °C and
5% CO2. At 90% conﬂuence, cells were trypsinised, collected and seeded
at 30,000 cells/sample/500 μl on composites for direct contact experi-
ments or 30,000 cells/well/500 μl in 48-well plates for indirect contact
experiments. The next day, in the case direct-contact cytocompatibility
experiments, medium change was performed and then subsequently
every 2–3 days of culture until Day 21. Cell metabolic activity (-
Section 2.11) measurements were taken on Day 1, 4, 7, 14 and 21 of
culture.
2.10. Indirect-contact cytocompatibility assessment
Effect of degradation products of composites on MG63 cells was
evaluated using indirect contact cytocompatibility experiments,
wherein composites were prepared for cell culture (Section 2.8) and
500 μl of culture medium per sample was added. Same day, cells were
also seeded as described in Section 2.9 in 48-well plates. The next day,
the eluted culture medium from samples was removed and replaced
with fresh culture medium. The removed medium was added onto the
cells seeded a day before in well plates. This was repeated for the next
6 days. On Day 1, 4 and 7 of culture in elutedmedium, cell metabolic ac-
tivity was assessed as described in next section.
2.11. Cell metabolic activity assay
Cell metabolic activity was measured using Resazurin Reduction
assay. The Resazurin Stock solution of 1 mMwas prepared in deionised
water and for working solution, the stock was diluted 1 in 10 with pre-
warmed Hanks Balanced Salt Solution. At selected time points, culture
medium was removed and cells were washed with PBS before adding
Resazurin working solution and incubating at 37 °C and 5% CO2.
Resazurinworking solutionwas also added to threewells or composites
containing no cells (blanks). During the kinetic phase of reaction, 100 μl
aliquots per well were taken and the ﬂuorescence intensity was mea-
sured using530nmexcitation and590nmemissionﬁlters on an Inﬁnite
F200 PRO microplate reader (Tecan, UK). Cell metabolic activity was
expressed after subtracting the reading for unreduced (blank) reagents,
normalising to reaction time and then normalising to Day 1 measure-
ments of 0 mg/ml aragonite containing WPI gels for direct-contact
cytocompatibility experiments or to Day 1 measurements of control
(medium with no hydrogel composites) for indirect-contact
cytocompatibility experiments. Results from two independent experi-
ments were combined and shown.
2.12. Giemsa stain
Giemsa's solution is a mixture of methylene blue, eosin, and Azure B
and stains the nucleus dark blue and cytoplasm blue to pink. Culture
medium was removed, samples were ﬁxed with 3.7% PFA in PBS for
10 min, then washed with deionised water to remove any residual ﬁx-
ative before immersing them in Giemsa stain for 30 min at room tem-
perature (RT). Samples were then washed with deionised water to
remove any residual stain and were ready to be imaged.
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2.13. Alkaline phosphatase activity and DNA assays
On Day 21 of direct-contact cytocompatibility experiments, the cul-
ture medium was removed and the cells were washed with PBS before
adding sterile deionisedwater (same volume as culturemedium). Sam-
ples were lysed through three cycles of freeze thawing at−80 °C. Alka-
line phosphatase (ALP) activity was measured using p-Nitrophenyl
Phosphate (PNPP) Phosphatase Substrate (Thermo Scientiﬁc, UK).
Brieﬂy, 100 μl of cell lysates (or sterile distilled water for 3 blank wells
to remove background) and 100 μl of substrate was added to each
assay well and absorbance at 405 nm was measured on an Inﬁnite
F200 PRO microplate reader for 80 min. For DNA assay, cell lysates
were diluted 1 in 10 by adding 10 μl lysates to 90 μl buffer provided
by the kit. The test lysates were loaded on to a ﬂat transparent 96-
well plate (Grenier) and DNA content was quantiﬁed using Quant-i™
PicoGreen® dsDNA Assay kit (Thermoﬁsher Scientiﬁc, UK) according
tomanufacturer's instruction. Brieﬂy, 100 μl of PicoGreenworking solu-
tion (1 in 200 dilution of dye with Tris-EDTA buffer) was added to each
testwell and three blankwells containing onlywater. After 10min incu-
bation period at RT, ﬂorescence intensity readings were taken on an In-
ﬁnite F200 PROmicroplate reader using 480 nm excitation and 520 nm
emission ﬁlters. The DNA concentration was extrapolated using a stan-
dard curve prepared from standard DNA calf thymus provided with the
assay kit. ALP activity was expressed after normalising to respective
DNA contents of the samples and then to Day 1 measurements of
0 mg/ml aragonite containing WPI hydrogels.
2.14. Alizarin red S staining
Alizarin red S staining was performed to assess amount of cal-
cium in the extracellular matrix. Culture medium was removed
and cells were washed once with PBS at RT for 5 min, before ﬁxing
WPI0 WPI100 WPI200 WPI300
50
0x
1,
00
0x
5,
00
0x
A
3D
 
to
m
o
gr
a
ph
y
Tr
a
n
sv
e
rs
e-
se
ct
io
n
B
Fig. 1.Morphological analysis of WPI-based biocomposites. (A) Scanning electron micrographs of transverse-sections were acquired at three magniﬁcations of 500×, 1000× and 5000×
with scale bars of 10 μm, 10 μm and 1 μm, respectively. (B) 3D tomography and cross-sectional view of each composite is shown. Blue- WPI gel and and pink - aragonite. Scale bar =
1 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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them with 3.7% paraformaldehyde in PBS for 10 min. After remov-
ing the ﬁxative, cells were again washed with PBS and then stained
with 1% (wt/vol) solution of Alizarin red S for 30 min at RT. Then
staining solution was removed and cells were washed with
deionised water to remove any unbound stain. At this stage images
of cells were taken.
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Fig. 2. Heat maps and histograms (in μm) of (A) pore and (B) strut size distributions in different WPI-based biocomposites. Scale bars = 1 mm.
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2.15. Statistical analysis
All statistical analyses were performed using GraphPad Prism ver-
sion 7.0d. Two experiments for every assessment were performed.
Mean and standard deviation were computed for at least 6 replicates
in all experiments. For comparisons one-way or two-way ANOVA was
performed. WPI gel type and Day were two ﬁxed factors. For pairwise
comparisons, post-hoc analyses using Least Signiﬁcant Difference,
equivalent to no adjustments, were carried out. P values b .05were con-
sidered signiﬁcant. *, ** and *** indicate p b .05, p b .005 and p b .0005,
respectively.
3. Results
3.1. Morpho-structural characterization of WPI-based biocomposites
SEM images showed that all the biocomposites present a typical bi-
phasic microstructure, consisting in aragonite microrods dispersed into
theWPI continuousmatrix (Fig. 1A),while the control sampleWPI0 has
a typical appearance for amorphous polymers. It can be noticed that a
smaller number of aragonite micro-rods are embedded into the
WPI100 polymer matrix, while increasing the amount of mineral from
WPI100 to WPI300 generated a more homogeneous distribution of
the aragonite crystals in the biocomposites.
Additionally, aragonite agglomerates appeared to have different di-
mensions in all the investigated scaffolds. The microstructure of these
particles was investigated before autoclaving (Supplemental Fig. 1).
They also exhibited rod-likemorphology, having various sizes. No obvi-
ous difference in morphology was observed between the particles be-
fore autoclaving and the particles in autoclaved composite samples.
To study the internal architecture of composites, micro-CT analysis
was also performed. The results (Fig. 1B) indicated that at smaller ara-
gonite content, themineral concentratedmostly near the edges of cylin-
drical WPI100 and WPI200 samples, while it was more homogenously
dispersed in the composite with the highest mineral content, WPI300.
As expected, the control sample,WPI0, wasmonophasic, corresponding
to the polymer matrix. Using image analysis, a volumetric porosity of
3.3%, 12.9%, 9.1% and 15.7% was calculated for WPI0, WPI100, WPI200
and WPI300, respectively.
Further image analysis revealed variable distribution of pores and
struts across all composites (Fig. 2). Overall, the largest pores up to
778 μm and 369 μmwere present inWPI200 andWPI300, respectively;
while the largest struts of 1014 μm and 994 μmwere present in WPI0
and WPI200, respectively. For all samples, the majority of pores
Fig. 3. (A) FTIR spectra and (B) compressionmodulusmeasurements ofWPI-based biocomposites. ** and *** indicate p b .005 and p b .0005, relative toWPI0, unless otherwisementioned.
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were b 200 μm in diameter, however struts were much larger with a
mean width of 297 μm in the case of WPI200, compared to all other
samples. For WPI0, WPI100 and WPI300, there seemed to be larger
struts near the edges and smaller struts in the centre of the composites.
On the other hand, in WPI300 there appeared to be several layers of
larger and smaller struts from top to bottom. In WPI100, the pore den-
sity reduced from top to bottom of the sample, which was not the
case in WPI200 and WPI300. In WPI0, there were larger pores in the
centre of the composite compared to its circumferential edges.
3.2. FTIR analysis
The chemical composition of biocomposites was assessed through
FTIR analysis as it helps identify organic and inorganic compounds
(Fig. 3A). Pure aragonite showed typical peaks for CO3
2−: ν1 - symmetric
stretching at ~1083 cm−1, ν2 - out-of-plane bending modes at
~854 cm−1, ν3 - a very broad doubly degenerate planar asymmetric
stretching at ~1490 cm−1 and ν4 - doubly degenerate in-plane bending
at ~700 cm−1 and ~712 cm−1. There is also a peak at ~1786 cm−1 due to
combination of the vibration frequencies assigned between ν1 and ν4
[19,20]. These peaks were also visible for WPI100, WPI200 and
WPI300 and as the concentration of aragonite increased in hydrogels,
the peak intensities also increased. As expected, these peaks were not
present in WPI0, instead WPI0 exhibited typical amide I peak at
~1623 cm−1 from C_O stretching, amide II peak at ~1511 cm−1 from
N\\H bending coupled with C\\N stretching and amide III peaks at
~1385 cm−1 and ~1214 cm−1 from C\\N stretching and N\\H bending
[21]. It was interesting to note that as the aragonite content increased,
the amide III peak at ~1385 cm−1 diminished and ν3 peak was more
prominent. This illustrated that hydrogels were chemically modiﬁed
after aragonite addition.
3.3. Mechanical properties of biocomposites
Generally, composites containing aragonite had higher compression
modulus than control samples (Fig. 3B). There was no clear correlation
between resistance to compressive loading and aragonite concentra-
tion. However, the highest compression modulus was observed for
WPI300 (3.16 ± 0.70 MPa). These results indicated that incorporation
of aragonite particles in WPI-based composites had a reinforcing effect
on the mechanical strength of composites.
3.4. Swelling analysis of biocomposites
Swelling behaviour of the studied composites is presented in Fig. 4A.
After 1 day of incubation in SBF all samples swelled and the swelling
ratio increased with increasing amount of aragonite from 2.5 ± 1.1%
for WPI0 to 6.9 ± 2.9% for WPI300. This trend was apparent on all sub-
sequent time points with statistically signiﬁcant differences observed
on Days 4, 7, 14 and 21. Additionally, all samples swelled between Day
1 to Day 4, except WPI100, for which the swelling ratio did not change
until Day 28, amounting to 1.3 ± 1.6%. In the case ofWPI100, the swell-
ing ratio decreased fromDay 4 to Day 28, measuring 2.2± 2.7%. Finally,
the swelling ratio ofWPI200 andWPI300 did not change betweenDay 4
to Day 21, it dropped to 1.8 ± 0.6% and 4.3 ± 2.8%, respectively on Day
28.
3.5. Degradation of biocomposites
Degradation of composites in PBS was measured over 28 days using
BCAassay (Fig. 4B). All composites exhibited similar degradation behav-
iour until Day 7, where the release of proteinwas b1.0mg/ml. However,
signiﬁcant differences were observed on Days 14, 21 and 28 of incuba-
tion in PBS. The highest degradation rate was for WPI200 and WPI300,
followed by WPI100 and slowest in the case of WPI0. At the end of
28 days protein content measured 3.5 ± 0.2, 3.3 ± 0.4, 2.7 ± 0.3 and
2.0 ± 0.4 mg/ml, respectively.
3.6. Cell attachment and growth on biocomposites
To assess osteoblastic MG63 cell attachment and growth cells were
seeded on composites and cell metabolic activity was measured from
Day 1 to Day 21 of culture (Fig. 5A). There were no signiﬁcant differ-
ences between conditions on Day 1 and Day 4 of culture. However,
when cell metabolic activity was measured on subsequent time points
there was higher cell metabolic activity with increasing aragonite con-
tent on Days 7, 14 and 21 of culture indicating the cell numbers in-
creased on these scaffolds suggestive of proliferation. SEM imaging
was performed on Day 7, where the cells showed a rounded morphol-
ogy in dehydrated samples of all conditions except WPI300 (Supple-
mentary Fig. 2); and Giemsa staining was performed on hydrated
samples fromDay 21,which conﬁrmed that as the aragonite content in-
creased in WPI hydrogels, the cell numbers also increased.
3.7. Alkaline phosphatase activity of cells on biocomposites
ALP activity of MG63 cells was measured after 21 days of culture on
composites and the results in Fig. 5C showed nearly 10 times higher
mean ALP activity of cells grown onWPI300 compared to all other con-
ditions. These results strongly suggested that aragonite in WPI300 may
have supported the cells to mature as ALP is upregulated prior to bone
cell mineralisation.
3.8. Effect of degradation products of biocomposites
To investigate if cells were affected by degradation products of WPI-
based composites, cells were grown in medium containing composite
eluate. On days 1 and 4 of culture, there were no statistically signiﬁcant
differences between any of the conditions (Fig. 6A). On the Day 7, there
was slightly higher cell metabolic activity in medium eluate fromWPI0
or WPI200 gels relative to control.
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To further assess thematrix formation by cells under the inﬂuence of
the degradation products of biocomposites, cells were grown in eluted
media for 21 days and then stained with Alizarin red S on Day 21 of cul-
ture. The cells grown in control (medium only) and WPI0-conditioned
medium had no mineral-like deposits (Fig. 6B). However, for cells
grown in medium eluted with WPI100, WPI200 or WPI300, there
were several mineral-like deposits visible, with highest in the case of
WPI300 that stained positively for Alizarin red S.
4. Discussion
This study established that novel WPI-aragonite biocomposite
hydrogels can be manufactured via an inexpensive method. Moreover,
these biocomposites are mechanically stable, undergo swelling, degra-
dation and are also cytocompatible with osteogenic potential.
Recently, Dziadek et al. [12] reported inhomogeneous distribution of
α-TCP particles and presence of porosity inWPI/gelatin/α-TCP compos-
ite hydrogels, irrespective of α-TCP concentration used. They showed
more pores at the top compared to the bottom of the composites.
Such an architecture of composites was attributed to rapid dissolution
of calcium ions from α-TCP in the WPI/gelatin solution that may have
caused the WPI around α-TCP to form aggregates, thus hindering their
uniform distribution in the solution. In this study, the addition of
aragonite at 100mg/ml and 200mg/ml to aWPI solution also lead to in-
homogeneous distribution of aragonite inside the composites. However,
this was not seen in the case of WPI300 (40% wt/volWPI gel containing
300mg/ml of aragonite). The composites had a porous architecture and
the porosity increased almost 3–5 times after incorporation of arago-
nite. Porosity decreased with increasing distance from the top of the
WPI100 composite but this was not observed for WPI200 and WPI300,
where pores seemed to more evenly distributed. At the same time, big-
ger strut sizes were clearly visible in the circumferential edges ofWPI0,
WPI100 and WPI200 but not WPI300, where the strut distribution was
again more even.
Such variation in the composites structure in the present study may
be attributed to uneven gelation process of the WPI solution. The solu-
tion near the edgesmay have heated up faster than the internal regions
causing delayed gelation of the internal regions and hence, more pores
in that area.Moreover, as the aragonite content increased in theWPI so-
lution, more calcium ionsmay have been released that affected gelation
process differently in different composites. InWPI100 andWPI200 ara-
gonite was mostly concentrated near the edges of the composites,
therefore, these area would have undergone gelation even faster than
in WPI0, causing the generation of even bigger pores in the internal re-
gions ofWPI100 andWPI200 compared toWPI0. In the case ofWPI300,
as aragonite was more evenly spread across the WPI solution, this may
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have resulted in more homogeneous release of calcium ions across the
solution, enabling a more homogeneous gelation process and pore dis-
tribution. However, this remains speculative in the absence of further
data. In future, other gelation methodologies such as using infrared
assistedmicrowave heating or high pressures [8] and higher concentra-
tions of aragonite inWPI hydrogels may be investigated to obtain more
homogeneous porosity and aragonite distribution in composites. The
use of high pressure to induce gelation of dairy products is standard
practice in the food industry [22].
It was expected that with linear increase in aragonite content, the
mechanical strength of the composites would also increase in a similar
fashion. However, no such linearity was observed but WPI300 had the
highest compression modulus measured. This may again be due to the
uneven distribution of aragonite and pores in WPI100 and WPI200. In-
terestingly, however, therewas a clear positive correlation between ara-
gonite content and MG63 cell metabolic activity and also between
aragonite content and ALP activity of cells grown directly on compos-
ites, which strongly suggested that addition of aragonite was beneﬁcial
for cell proliferation and osteogenic onset.
Several studies have also shown that WP/WPI enhances prolifera-
tion of several cell types such as enteroendocrine cells [23], MC3T3-E1
osteoblastic cells [24], foetal rat calvariae osteoblasts [25], osteoblast-
like Saos-2 cell, human neonatal dermal ﬁbroblast [26] and immortal-
ized human foetal osteoblast [27] when supplemented in culture me-
dium. It is suggested that this effect is due to presence of β-
lactoglobulin in WP/WPI, which has recently been shown to inﬂuence
immunity and proliferation via receptor-mediated membrane IgM
receptor in murine hybridoma cells [28]. In the present study, there
was increased protein content released by composites as the aragonite
content in them increased over a period of 28 days of degradation,
which suggests that β-lactoglobulin from these composites may also
have affected proliferation of cells grown on these composites.
WPI0 had amaximumpore size of 60 μmbut after addition of arago-
nite in WPI100, WPI200 and WPI300 it was measured at 198, 778 and
369 μm, respectively. These pore sizes are within the recommended
pore size distribution of N100 μm width for 3D scaffolds suitable for
bone regeneration in vivo as smaller pores limit cell penetration and
vascularisation, though they are useful for nutrient and oxygen supply
and removal of waste products [29,30]. As the composites swelled
more when the aragonite content increased by the end of 21 days of in-
cubation, this may have allowed retention of more nutrients and easier
removal of wastes in WPI300 compared to other composites, enabling
cell growth.
Osteoblasts are able to sense local calcium concentration gradients
created by osteoclast activity in bone and calcium is known to regulate
differentiation of osteoblast differentiation and mineralisation process
[31,32]. Higher calcium concentration can lead to osteogenic differenti-
ation but toxic doses may lead to stress induced apoptosis-like cell
death [33]. Our study showed that degradation products of WPI-based
biocomposites were non-toxic and did not affect cell growth.Moreover,
WPI300 had signs of intense mineralisation in the extracellular matrix
by the end of 21 days of culture, maybe due to deposition of calcium
salts by the cells [34,35], and/or due to degraded aragonite particles
which may have directly precipitated onto the matrix. Altogether, our
Fig. 6. Assessment of MG63 cytocompatibility with WPI-based biocomposites via indirect-contact experiments. (A) Mean ± S.D. of cell metabolic activity after over 7 days of culture in
media conditioned with biocomposites (n= 12). * indicates p b .05, relative to control (medium only). (B) Alizarin Red stained cells after 21 days of exposure to conditioned media.
Arrows - transparent debris, arrow heads - positive Alizarin red S staining. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version
of this article.)
9D. Gupta et al. / Materials and Design 188 (2020) 108408
study showed that WPI-aragonite biocomposites are cytocompatible
and are potential candidates for bone tissue engineering applications.
In future it would be interesting to investigate the response of bone
marrow derived mesenchymal stem cells onWPI-based gels via assess-
ment of gene expression and extracellular matrix deposition for bone
regeneration applications.
5. Conclusion
The present work describes the physiochemical, mechanical, degra-
dation and cytocompatibility properties of novel and inexpensive
biocomposite hydrogels fabricated using WPI, a waste product of dairy
industry and synthetic aragonite. The composites swelled more and re-
leased more protein under physiologically relevant degrading condi-
tions as aragonite content increased from 0, 100, 200 to 300 mg/ml in
the WPI solution. Mechanical strength also increased after addition of
aragonite and the highest value was obtained for composites with
300 mg/ml of aragonite. All composites were porous pores N100 μm in
diameter were present only in aragonite containing composites and
the most even distribution of aragonite and pores was present in
hydrogels with the highest aragonite content. The composites were
supportive of osteoblast-like cell proliferation over a period of 3 weeks
of culture and as the aragonite concentration increased, the cell prolifer-
ation and ALP activity was higher. The degradation products of these
biocomposites were non-cytotoxic and may have induced
mineralisation, indicating the osteoinductive nature of these
biocomposites.
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